HEADER LIPOPROTEINULLNTIGEN 23-OCT-02 1O75 TITLE TP47, THE 47-KILODALTON LIPOPROTEIN OF TREPONEMA PALLIDUM COMPND MOL_ID: 1; COMPND 2 MOLECULE: 47 KDA MEMBRANE ANTIGEN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TREPONEMA PALLIDUM; SOURCE 3 ORGANISM_TAXID: 160; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI DH5[ALPHA]; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 668369; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PASK-IBA7 KEYWDS LIPOPROTEINULLNTIGEN, PENICILLIN-BINDING PROTEIN, INTEGRAL MEMBRANE KEYWDS 2 LIPOPROTEIN, IMMUNOGEN, FOUR-DOMAIN PROTEIN, ANTIGEN, LIPOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.K.DEKA,M.MACHIUS,M.V.NORGARD,D.R.TOMCHICK REVDAT 5 08-MAY-24 1O75 1 HETSYN REVDAT 4 29-JUL-20 1O75 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 28-FEB-18 1O75 1 SOURCE JRNL REVDAT 2 24-FEB-09 1O75 1 VERSN REVDAT 1 01-NOV-02 1O75 0 JRNL AUTH R.K.DEKA,M.MACHIUS,M.V.NORGARD,D.R.TOMCHICK JRNL TITL CRYSTAL STRUCTURE OF THE 47-KDA LIPOPROTEIN OF TREPONEMA JRNL TITL 2 PALLIDUM REVEALS A NOVEL PENICILLIN-BINDING PROTEIN. JRNL REF J. BIOL. CHEM. V. 277 41857 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 12196546 JRNL DOI 10.1074/JBC.M207402200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.M.WEIGEL,J.D.RADOLF,M.V.NORGARD REMARK 1 TITL THE 47-KDA MAJOR LIPOPROTEIN IMMUNOGEN OF TREPONEMA PALLIDUM REMARK 1 TITL 2 IS A PENICILLIN-BINDING PROTEIN WITH CARBOXYPEPTIDASE REMARK 1 TITL 3 ACTIVITY REMARK 1 REF PROC.NATL.ACAD.SCI. USA V. 91 11611 1994 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 7972112 REMARK 1 DOI 10.1073/PNAS.91.24.11611 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 3136619.470 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 101021 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 5036 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8287 REMARK 3 BIN R VALUE (WORKING SET) : 0.2910 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 409 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6237 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 619 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.56000 REMARK 3 B22 (A**2) : 0.56000 REMARK 3 B33 (A**2) : -1.12000 REMARK 3 B12 (A**2) : 0.91000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.22 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.410 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.580 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.480 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.470 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.700 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 52.70 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : LIGANDS.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : LIGANDS.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1O75 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-OCT-02. REMARK 100 THE DEPOSITION ID IS D_1290011580. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97938 REMARK 200 MONOCHROMATOR : GRAPHITE DOUBLE MONOCHROMATOR REMARK 200 OPTICS : DUAL SLITS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : APS SBC2 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 478972 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 28.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.70200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: MLPHARE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 32% PEG 4000, 100 MM SODIUM CITRATE PH REMARK 280 5.6, 200 MM AMMONIUM ACETATE,3% (W/V) DEXTRAN SULFATE 8000, PH REMARK 280 5.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 100.77400 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 50.38700 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 50.38700 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 100.77400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE OLIGOMERIZATION STATE OF THE PROTEIN IN REMARK 300 SOLUTIONIS MONOMERIC, AS DETERMINED VIA REMARK 300 ANALYTICALULTRACENTRIFUGATION. THE BIOLOGICALLY REMARK 300 SIGNIFICANTOLIGOMERIZATION STATE OF THE MEMBRANCE REMARK 300 BOUNDLIPOPROTIEN IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THIS MEMBRANE LIPOPROTEIN IS A PATHOGEN-SPECIFIC MEMBRANE REMARK 400 IMMUNOGEN FOUND ONLY IN TREPONEMES. MAY PLAY AN IMPORTANT REMARK 400 ROLE IN THE CELL ENVELOPE OF VIRULENT TREPONEMA. REMARK 400 REMARK 400 ENGINEERED MUTATION HIS 24 SER AND HIS 28 SER, CHAINS A, B REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 1 REMARK 465 GLY A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 SER A 5 REMARK 465 HIS A 6 REMARK 465 GLY A 35 REMARK 465 ASN A 36 REMARK 465 ALA A 37 REMARK 465 GLU A 38 REMARK 465 ALA A 39 REMARK 465 ASP A 40 REMARK 465 ARG A 41 REMARK 465 ALA A 42 REMARK 465 GLY A 43 REMARK 465 GLN A 415 REMARK 465 CYS B 1 REMARK 465 GLY B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 SER B 5 REMARK 465 HIS B 6 REMARK 465 GLY B 35 REMARK 465 ASN B 36 REMARK 465 ALA B 37 REMARK 465 GLU B 38 REMARK 465 ALA B 39 REMARK 465 ALA B 414 REMARK 465 GLN B 415 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 27 -163.47 -124.85 REMARK 500 MET A 49 -122.48 -97.79 REMARK 500 ASP A 196 32.65 -140.69 REMARK 500 ASP A 215 -67.42 -92.33 REMARK 500 SER A 281 -58.60 79.15 REMARK 500 ASN A 338 71.18 74.08 REMARK 500 ASP A 368 127.00 -35.06 REMARK 500 GLN B 27 -162.57 -125.63 REMARK 500 MET B 49 -127.16 -92.25 REMARK 500 VAL B 53 90.37 -65.62 REMARK 500 ASP B 196 33.84 -142.44 REMARK 500 ASP B 215 -61.27 -95.97 REMARK 500 SER B 281 -47.99 81.85 REMARK 500 ASP B 368 -80.43 -10.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FIRST 20 RESIDUES OF THIS SEQUENCE ENCODES FOR THE REMARK 999 LIPIDATED MEMBRANE ANCHOR. THE POST-TRANSLATIONALLY REMARK 999 MODIFIED N-TERMINAL CYSTEINE OF NATIVE TP47 WAS REMARK 999 DESIGNATED AS AMINO ACID #1. ONLY RESIDUES 2-415 WERE REMARK 999 EXPRESSED. DBREF 1O75 A 1 415 UNP P29723 TA47_TREPA 20 434 DBREF 1O75 B 1 415 UNP P29723 TA47_TREPA 20 434 SEQADV 1O75 SER A 5 UNP P29723 HIS 24 ENGINEERED MUTATION SEQADV 1O75 SER A 9 UNP P29273 HIS 28 ENGINEERED MUTATION SEQADV 1O75 SER B 5 UNP P29723 HIS 24 ENGINEERED MUTATION SEQADV 1O75 SER B 9 UNP P29273 HIS 28 ENGINEERED MUTATION SEQRES 1 A 415 CYS GLY SER SER SER HIS GLU THR SER TYR GLY TYR ALA SEQRES 2 A 415 THR LEU SER TYR ALA ASP TYR TRP ALA GLY GLU LEU GLY SEQRES 3 A 415 GLN SER ARG ASP VAL LEU LEU ALA GLY ASN ALA GLU ALA SEQRES 4 A 415 ASP ARG ALA GLY ASP LEU ASP ALA GLY MET PHE ASP ALA SEQRES 5 A 415 VAL SER ARG ALA THR HIS GLY HIS GLY ALA PHE ARG GLN SEQRES 6 A 415 GLN PHE GLN TYR ALA VAL GLU VAL LEU GLY GLU LYS VAL SEQRES 7 A 415 LEU SER LYS GLN GLU THR GLU ASP SER ARG GLY ARG LYS SEQRES 8 A 415 LYS TRP GLU TYR GLU THR ASP PRO SER VAL THR LYS MET SEQRES 9 A 415 VAL ARG ALA SER ALA SER PHE GLN ASP LEU GLY GLU ASP SEQRES 10 A 415 GLY GLU ILE LYS PHE GLU ALA VAL GLU GLY ALA VAL ALA SEQRES 11 A 415 LEU ALA ASP ARG ALA SER SER PHE MET VAL ASP SER GLU SEQRES 12 A 415 GLU TYR LYS ILE THR ASN VAL LYS VAL HIS GLY MET LYS SEQRES 13 A 415 PHE VAL PRO VAL ALA VAL PRO HIS GLU LEU LYS GLY ILE SEQRES 14 A 415 ALA LYS GLU LYS PHE HIS PHE VAL GLU ASP SER ARG VAL SEQRES 15 A 415 THR GLU ASN THR ASN GLY LEU LYS THR MET LEU THR GLU SEQRES 16 A 415 ASP SER PHE SER ALA ARG LYS VAL SER SER MET GLU SER SEQRES 17 A 415 PRO HIS ASP LEU VAL VAL ASP THR VAL GLY THR GLY TYR SEQRES 18 A 415 HIS SER ARG PHE GLY SER ASP ALA GLU ALA SER VAL MET SEQRES 19 A 415 LEU LYS ARG ALA ASP GLY SER GLU LEU SER HIS ARG GLU SEQRES 20 A 415 PHE ILE ASP TYR VAL MET ASN PHE ASN THR VAL ARG TYR SEQRES 21 A 415 ASP TYR TYR GLY ASP ASP ALA SER TYR THR ASN LEU MET SEQRES 22 A 415 ALA SER TYR GLY THR LYS HIS SER ALA ASP SER TRP TRP SEQRES 23 A 415 LYS THR GLY ARG VAL PRO ARG ILE SER CYS GLY ILE ASN SEQRES 24 A 415 TYR GLY PHE ASP ARG PHE LYS GLY SER GLY PRO GLY TYR SEQRES 25 A 415 TYR ARG LEU THR LEU ILE ALA ASN GLY TYR ARG ASP VAL SEQRES 26 A 415 VAL ALA ASP VAL ARG PHE LEU PRO LYS TYR GLU GLY ASN SEQRES 27 A 415 ILE ASP ILE GLY LEU LYS GLY LYS VAL LEU THR ILE GLY SEQRES 28 A 415 GLY ALA ASP ALA GLU THR LEU MET ASP ALA ALA VAL ASP SEQRES 29 A 415 VAL PHE ALA ASP GLY GLN PRO LYS LEU VAL SER ASP GLN SEQRES 30 A 415 ALA VAL SER LEU GLY GLN ASN VAL LEU SER ALA ASP PHE SEQRES 31 A 415 THR PRO GLY THR GLU TYR THR VAL GLU VAL ARG PHE LYS SEQRES 32 A 415 GLU PHE GLY SER VAL ARG ALA LYS VAL VAL ALA GLN SEQRES 1 B 415 CYS GLY SER SER SER HIS GLU THR SER TYR GLY TYR ALA SEQRES 2 B 415 THR LEU SER TYR ALA ASP TYR TRP ALA GLY GLU LEU GLY SEQRES 3 B 415 GLN SER ARG ASP VAL LEU LEU ALA GLY ASN ALA GLU ALA SEQRES 4 B 415 ASP ARG ALA GLY ASP LEU ASP ALA GLY MET PHE ASP ALA SEQRES 5 B 415 VAL SER ARG ALA THR HIS GLY HIS GLY ALA PHE ARG GLN SEQRES 6 B 415 GLN PHE GLN TYR ALA VAL GLU VAL LEU GLY GLU LYS VAL SEQRES 7 B 415 LEU SER LYS GLN GLU THR GLU ASP SER ARG GLY ARG LYS SEQRES 8 B 415 LYS TRP GLU TYR GLU THR ASP PRO SER VAL THR LYS MET SEQRES 9 B 415 VAL ARG ALA SER ALA SER PHE GLN ASP LEU GLY GLU ASP SEQRES 10 B 415 GLY GLU ILE LYS PHE GLU ALA VAL GLU GLY ALA VAL ALA SEQRES 11 B 415 LEU ALA ASP ARG ALA SER SER PHE MET VAL ASP SER GLU SEQRES 12 B 415 GLU TYR LYS ILE THR ASN VAL LYS VAL HIS GLY MET LYS SEQRES 13 B 415 PHE VAL PRO VAL ALA VAL PRO HIS GLU LEU LYS GLY ILE SEQRES 14 B 415 ALA LYS GLU LYS PHE HIS PHE VAL GLU ASP SER ARG VAL SEQRES 15 B 415 THR GLU ASN THR ASN GLY LEU LYS THR MET LEU THR GLU SEQRES 16 B 415 ASP SER PHE SER ALA ARG LYS VAL SER SER MET GLU SER SEQRES 17 B 415 PRO HIS ASP LEU VAL VAL ASP THR VAL GLY THR GLY TYR SEQRES 18 B 415 HIS SER ARG PHE GLY SER ASP ALA GLU ALA SER VAL MET SEQRES 19 B 415 LEU LYS ARG ALA ASP GLY SER GLU LEU SER HIS ARG GLU SEQRES 20 B 415 PHE ILE ASP TYR VAL MET ASN PHE ASN THR VAL ARG TYR SEQRES 21 B 415 ASP TYR TYR GLY ASP ASP ALA SER TYR THR ASN LEU MET SEQRES 22 B 415 ALA SER TYR GLY THR LYS HIS SER ALA ASP SER TRP TRP SEQRES 23 B 415 LYS THR GLY ARG VAL PRO ARG ILE SER CYS GLY ILE ASN SEQRES 24 B 415 TYR GLY PHE ASP ARG PHE LYS GLY SER GLY PRO GLY TYR SEQRES 25 B 415 TYR ARG LEU THR LEU ILE ALA ASN GLY TYR ARG ASP VAL SEQRES 26 B 415 VAL ALA ASP VAL ARG PHE LEU PRO LYS TYR GLU GLY ASN SEQRES 27 B 415 ILE ASP ILE GLY LEU LYS GLY LYS VAL LEU THR ILE GLY SEQRES 28 B 415 GLY ALA ASP ALA GLU THR LEU MET ASP ALA ALA VAL ASP SEQRES 29 B 415 VAL PHE ALA ASP GLY GLN PRO LYS LEU VAL SER ASP GLN SEQRES 30 B 415 ALA VAL SER LEU GLY GLN ASN VAL LEU SER ALA ASP PHE SEQRES 31 B 415 THR PRO GLY THR GLU TYR THR VAL GLU VAL ARG PHE LYS SEQRES 32 B 415 GLU PHE GLY SER VAL ARG ALA LYS VAL VAL ALA GLN HET PDX C 1 20 HET PDX C 2 19 HET XE A1415 1 HET XE A1416 1 HET XE B1415 1 HET XE B1416 1 HET XE B1417 1 HETNAM PDX 2,3-DI-O-SULFO-ALPHA-D-GLUCOPYRANOSE HETNAM XE XENON HETSYN PDX 2,3-DI-O-SULFO-ALPHA-D-GLUCOSE; 2,3-DI-O-SULFO-D- HETSYN 2 PDX GLUCOSE; 2,3-DI-O-SULFO-GLUCOSE FORMUL 3 PDX 2(C6 H12 O12 S2) FORMUL 4 XE 5(XE) FORMUL 9 HOH *619(H2 O) HELIX 1 1 TYR A 17 GLY A 26 1 10 HELIX 2 2 ARG A 29 LEU A 33 5 5 HELIX 3 3 GLY A 59 GLN A 66 1 8 HELIX 4 4 LEU A 166 HIS A 175 1 10 HELIX 5 5 SER A 244 MET A 253 1 10 HELIX 6 6 PHE A 302 LYS A 306 5 5 HELIX 7 7 TYR B 17 GLY B 26 1 10 HELIX 8 8 ARG B 29 LEU B 33 5 5 HELIX 9 9 GLY B 59 GLN B 66 1 8 HELIX 10 10 LEU B 166 PHE B 174 1 9 HELIX 11 11 SER B 244 MET B 253 1 10 HELIX 12 12 PHE B 302 LYS B 306 5 5 SHEET 1 AA 4 VAL A 53 ALA A 56 0 SHEET 2 AA 4 GLU A 143 PRO A 163 -1 O VAL A 150 N ARG A 55 SHEET 3 AA 4 THR A 8 SER A 16 -1 O SER A 9 N VAL A 162 SHEET 4 AA 4 VAL A 177 GLU A 178 -1 O VAL A 177 N TYR A 12 SHEET 1 AB 4 VAL A 53 ALA A 56 0 SHEET 2 AB 4 GLU A 143 PRO A 163 -1 O VAL A 150 N ARG A 55 SHEET 3 AB 4 TYR A 69 GLU A 85 -1 O ALA A 70 N HIS A 153 SHEET 4 AB 4 LYS A 91 ALA A 107 -1 O LYS A 92 N THR A 84 SHEET 1 AC 2 ALA A 109 LEU A 114 0 SHEET 2 AC 2 ILE A 120 ALA A 124 -1 O LYS A 121 N GLN A 112 SHEET 1 AD 4 LEU A 212 GLY A 218 0 SHEET 2 AD 4 ALA A 229 ARG A 237 -1 O SER A 232 N GLY A 218 SHEET 3 AD 4 ARG A 293 ILE A 298 -1 O ILE A 294 N VAL A 233 SHEET 4 AD 4 SER A 284 TRP A 285 -1 O TRP A 285 N SER A 295 SHEET 1 AE 4 ALA A 274 TYR A 276 0 SHEET 2 AE 4 PHE A 255 TYR A 262 -1 O TYR A 260 N TYR A 276 SHEET 3 AE 4 GLY A 311 ALA A 319 -1 O ARG A 314 N ASP A 261 SHEET 4 AE 4 VAL A 325 PHE A 331 -1 O VAL A 325 N LEU A 317 SHEET 1 AF 2 ASP A 340 GLY A 351 0 SHEET 2 AF 2 GLY A 382 PHE A 390 -1 O GLY A 382 N ILE A 350 SHEET 1 AG 4 VAL A 374 VAL A 379 0 SHEET 2 AG 4 ALA A 361 ALA A 367 -1 O ALA A 361 N VAL A 379 SHEET 3 AG 4 GLU A 395 ARG A 401 -1 O THR A 397 N PHE A 366 SHEET 4 AG 4 VAL A 408 VAL A 413 -1 O VAL A 408 N VAL A 400 SHEET 1 BA 4 VAL B 53 ALA B 56 0 SHEET 2 BA 4 GLU B 143 PRO B 163 -1 O VAL B 150 N ARG B 55 SHEET 3 BA 4 THR B 8 SER B 16 -1 O SER B 9 N VAL B 162 SHEET 4 BA 4 VAL B 177 GLU B 178 -1 O VAL B 177 N TYR B 12 SHEET 1 BB 4 VAL B 53 ALA B 56 0 SHEET 2 BB 4 GLU B 143 PRO B 163 -1 O VAL B 150 N ARG B 55 SHEET 3 BB 4 TYR B 69 GLU B 85 -1 O ALA B 70 N HIS B 153 SHEET 4 BB 4 LYS B 91 ALA B 107 -1 O LYS B 92 N THR B 84 SHEET 1 BC 2 ALA B 109 LEU B 114 0 SHEET 2 BC 2 ILE B 120 ALA B 124 -1 O LYS B 121 N GLN B 112 SHEET 1 BD 4 LEU B 212 GLY B 220 0 SHEET 2 BD 4 ALA B 229 ARG B 237 -1 O GLU B 230 N GLY B 220 SHEET 3 BD 4 ARG B 293 ILE B 298 -1 O ILE B 294 N VAL B 233 SHEET 4 BD 4 SER B 284 TRP B 285 -1 O TRP B 285 N SER B 295 SHEET 1 BE 4 ALA B 274 TYR B 276 0 SHEET 2 BE 4 PHE B 255 TYR B 262 -1 O TYR B 260 N TYR B 276 SHEET 3 BE 4 GLY B 311 ALA B 319 -1 O ARG B 314 N ASP B 261 SHEET 4 BE 4 VAL B 325 PHE B 331 -1 O VAL B 325 N LEU B 317 SHEET 1 BF 3 ASP B 340 LYS B 344 0 SHEET 2 BF 3 VAL B 347 GLY B 351 -1 O VAL B 347 N LYS B 344 SHEET 3 BF 3 GLY B 382 VAL B 385 -1 O GLY B 382 N ILE B 350 SHEET 1 BG 4 LYS B 372 ALA B 378 0 SHEET 2 BG 4 ALA B 362 ALA B 367 -1 O VAL B 363 N GLN B 377 SHEET 3 BG 4 TYR B 396 ARG B 401 -1 O THR B 397 N PHE B 366 SHEET 4 BG 4 VAL B 408 VAL B 412 -1 O VAL B 408 N VAL B 400 LINK O6 PDX C 1 C1 PDX C 2 1555 1555 1.42 CRYST1 128.931 128.931 151.161 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007756 0.004478 0.000000 0.00000 SCALE2 0.000000 0.008956 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006615 0.00000